Table 2 Univariate Analysis of Overall Survival among patients with Grade 2 and Grade Ependymomas (n = 19) treated with Fractionated Stereotactic Radiotherapy (FSRT).
From: Local radiotherapeutic management of ependymomas with fractionated stereotactic radiotherapy (FSRT)
Variable | 5 yrs. Survival rate | 10 yrs. Survival rate | P (Cox regression) |
|---|---|---|---|
all patients | 77% | 64% | |
age | |||
< 4 | 56% | 18% | 0.04 |
≥ 4 | 85% | 76% | |
gender | |||
female | 76% | 61% | 0.92 |
male | 78% | 66% | |
histology | |||
II | 87% | 52% | 0.92 |
III | 64% | 64% | |
tumor site | |||
supratentorial | 100% | 0% | 0.44 |
infratentorial | 72% | 55% | |
extent of surgery | |||
total resection | 100% | 67% | 0.54 |
subtotal resection | 70% | 62% | |
primary radiotherapy | |||
FSRT+CSI | - | - | 0.45 |
posterior fossa + boost | 78% | 78% | |
tumor bed | 100% | 100% |